Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Cancer|April 4, 2017
Chemoradiotherapy for Synchronous Multiple Primary Cancers with Esophageal Squamous Cell Carcinoma: a Case-control StudyQi-Wen Li, Yu-Jia Zhu, Wen-Wen Zhang, et al.
Frontiers in Psychiatry|March 22, 2021
Psychological Profiles of Chinese Patients With Hemodialysis During the Panic of Coronavirus Disease 2019Zhen-Hua Yang, Xiao-Ting Pan, Yu Chen, et al.
Scientific Reports|January 29, 2015
Concurrent radiotherapy and weekly chemotherapy of 5-fluorouracil and platinum agents for postoperative locoregional recurrence of oesophageal squamous cell carcinomaWen-Wen Zhang, Yu-Jia Zhu, Han Yang, et al.
Journal of Cellular Biochemistry|October 17, 2018
Differential expression profiles of long noncoding RNAs in synchronous multiple and solitary primary esophageal squamous cell carcinomas: A microarray analysisQi-Wen Li, Li Ma, Bo Qiu, et al.
Oncotarget|April 9, 2016
Effect of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy alone in nasopharyngeal carcinomaPu-Yun OuYang, Dingbo Shi, Rui Sun, et al.
Cancer Research and Treatment|May 4, 2019
Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and ToxicitiesNai-Bin Chen, Bo Qiu, Jun Zhang, et al.
Frontiers in Oncology|September 25, 2020
Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I-III Pulmonary Lymphoepithelioma-Like CarcinomaQi-Wen Li, Bo Qiu, Wan-Ming Hu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2015
Unconjugated Bilirubin Is a Novel Prognostic Biomarker for Nasopharyngeal Carcinoma and Inhibits Its Metastasis via Antioxidation ActivityCheng-Cheng Deng, Miao Xu, Jing Li, et al.
BMJ (Clinical Research Ed.)|April 15, 2025
Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trialWei-Hao Xie, Wei-Wei Xiao, Hui Chang, et al.
Pageof 2